🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Ingavirin

Found 11 matching trials

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

PHASE2

The objective of this study is to investigate the efficacy, safety, and tol...

Status

Recruiting

Location

Regional Budgetary Healthcare Institution "Kuvaev Ivanovo Clinical Hospital"

Start Date

2025-10-24

Trial ID

NCT07420985

Treatments Being Tested

Ingavirin Forte, 90 mg + 5 mg, Capsules Ingavirin Forte, 90 mg + 10 mg, Capsules Ingavirin Forte, 90 mg + 20 mg, Capsules Ingavirin, 90 mg, Capsules Placebo

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

PHASE3

The purpose of this study is to determine whether Ingavirin ® dosed 60 mg d...

Status

Completed

Location

GBOU VPO "Kazan State Medical University" of Ministry of Health of Russian Federation

Start Date

2012-01

Trial ID

NCT03206346

Treatments Being Tested

Ingavirin Placebo oral capsule

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

PHASE3

The study is planned to evaluate the therapeutic efficacy and safety of Ing...

Status

Completed

Location

Federal Research and Clinical Center of Physical and Chemical Medicine of the Federal Medical and Biological Agency

Start Date

2021-09-23

Trial ID

NCT05269290

Treatments Being Tested

Ingavirin®, syrup, 30 mg/5 ml Placebo

Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19

PHASE3

The primary objective of this study is to investigate the efficacy of Ingav...

Status

Completed

Location

Municipal Budgetary Institution of Healthcare "Central City Hospital of Novoshakhtinsk"

Start Date

2021-10-06

Trial ID

NCT05216497

Treatments Being Tested

Ingavirin®, 90 mg capsules Placebo

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

PHASE4

The purpose of this study is to determine whether Ingavirin® 90 mg once dai...

Status

Completed

Location

State educational institution of higher professional education "Chelyabinsk State Medical Academy of Federal Agency of Health Care and Social Development"

Start Date

2010-01

Trial ID

NCT03154515

Treatments Being Tested

Ingavirin Placebo

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

PHASE4

The study is planned to evaluate the therapeutic efficacy and safety of Ing...

Status

Unknown

Location

GBOU VPO "Rostov State Medical University" of Ministry of Health of Russian Federation

Start Date

2023-12-19

Trial ID

NCT06315400

Treatments Being Tested

Ingavirin®Placebo

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

PHASE3

The purpose of this study is to determine whether Ingavirin ® dosed 60 mg d...

Status

Completed

Location

GBOU VPO "Kazan State Medical University" of Ministry of Health of Russian Federation

Start Date

2014-08

Trial ID

NCT03191097

Treatments Being Tested

Ingavirin Placebo oral capsule

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers

PHASE1

This is a Single Center, First-in-human Study of Safety, Tolerability, and ...

Status

Recruiting

Location

State Budgetary Healthcare Institution of the City of Moscow "City Clinical Hospital No. 15 named after O.M. Filatov of the Department of Health of Moscow."

Start Date

2025-01-13

Trial ID

NCT06859333

Treatments Being Tested

Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg + 5 mg Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg + 10 mg Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg + 20 mg

Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

PHASE1

This study aims to evaluate the safety and pharmacokinetic profile of the a...

Status

Recruiting

Location

Federal Budgetary Institution of Science "North-West Public Health Research Center"

Start Date

2025-07-11

Trial ID

NCT07645534

Treatments Being Tested

Ingavirin forte, capsules, 90 mg + 20 mg Ingavirin, capsules, 90 mg

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.

PHASE3

The purpose of this study is to determine whether Ingavirin ® dosed 30 mg d...

Status

Completed

Location

GBOU VPO "Kazan State Medical University" of Ministry of Health of Russian Federation

Start Date

2016-01

Trial ID

NCT02644018

Treatments Being Tested

Imidazolyl ethanamide pentandioic acid placebo

Previous Next